undefined undefined

Showing 1-20 of 4397 articles

Coronary interventions

Clinical and Angiographic Outcomes of Crossing Techniques for Coronary Chronic Total Occlusions - The ISAR-CTO Registry

Xhepa E, Cassese S, Ndrepepa G, Joner M, Kufner S, Aytekin A, Lahmann AL, Voll F, Fusaro M, Pinieck S, Schunkert H, Kastrati A, Fusaro M

March 2, 2021 | 10.4244/EIJ-D-20-01248

Interventions for valvular disease

Fate of Tricuspid Regurgitation in Patients Undergoing Transcatheter Edge-to-Edge Mitral Valve Repair

Kavsur R, Iliadis C, Spieker M, Brachtendorf BM, Tiyerili V, Metze C, Horn P, Baldus S, Kelm M, Nickenig G, Pfister R, Westenfeld R, Becher M

March 2, 2021 | 10.4244/EIJ-D-20-01094

Coronary interventions

Clinical Outcomes By Angiographic Type Of Spontaneous Coronary Artery Dissection

Mori R, Macaya F, Giacobbe F, Salinas P, Pavani M, Boi A, Bettari L, Rolfo C, Porto I, Gonzalo N, Varbella F, Cerrato E, Escaned J

March 2, 2021 | 10.4244/EIJ-D-20-01275

Infective endocarditis after TAVI; IVUS assessment in valve-in-valve procedures; a mini focus on antithrombotic therapy in coronary interventions; an EAPCI position statement on elective procedures during COVID-19; and more…

Capodanno D

February 19, 2021

Cerebral embolic protection during TAVI: the game is not over

Bagur R, Sposato L

February 19, 2021 | 10.4244/EIJV16I14A201

Consolidating the value of the standardised ARC-HBR definition

Gargiulo G, Esposito G

February 19, 2021 | 10.4244/EIJV16I14A202

Thrombolysis in ST-elevation myocardial infarction is not dead

Kala P

February 19, 2021 | 10.4244/EIJV16I14A203

Ischaemic risk stratification after deferral of revascularisation on the basis of fractional flow reserve

Echavarría-Pinto M, van de Hoef T

February 19, 2021 | 10.4244/EIJV16I14A204

A review of recommendations for infective endocarditis prevention in patients undergoing transcatheter aortic valve implantation

Conen A, Stortecky S, Moreillon P, Hannan M, Franzeck F, Jeger R, Widmer A

February 19, 2021 | 10.4244/EIJ-D-19-00993

Heterogeneity of debris captured by cerebral embolic protection filters during TAVI

Kroon H, von der Thusen J, Ziviello F, van Wiechen M, Ooms J, Kardys I, Schipper M, van Gils L, Daemen J, de Jaegere P, Van Mieghem N

February 19, 2021 | 10.4244/EIJ-D-20-00744

Intravascular ultrasound assessment of coronary ostia following valve-in-valve transcatheter aortic valve implantation

Pighi M, Lunardi M, Pesarini G, Castriota F, Venturi G, Gottin L, Scarsini R, Ferrero V, Ribichini F

February 19, 2021 | 10.4244/EIJ-D-20-00611

Intravascular ultrasound guidance for valve-in-valve transcatheter pulmonary valve replacement

Kalinczuk L, Swierczewski M, Mintz G, Demkow M

February 19, 2021 | 10.4244/EIJ-D-20-00427

High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry

Nakamura M, Kadota K, Nakao K, Nakagawa Y, Shite J, Yokoi H, Kozuma K, Tanabe K, Iijima R, Harada A, Kuroda T, Murakami Y

February 19, 2021 | 10.4244/EIJ-D-20-00345

Ticagrelor versus clopidogrel in patients with STEMI treated with thrombolysis: the MIRTOS trial

Hamilos M, Kanakakis J, Anastasiou I, Karvounis C, Vasilikos V, Goudevenos J, Michalis L, Koutouzis M, Tsiafoutis I, Raisakis K, Stakos D, Hahalis G, Vardas P

February 19, 2021 | 10.4244/EIJ-D-20-00268

A prospective, multicentre, randomised, open-label trial to compare the efficacy and safety of clopidogrel versus ticagrelor in stabilised patients with acute myocardial infarction after percutaneous coronary intervention: rationale and design of the TALOS-AMI trial

Park M, Kim C, Kim M, Choo E, Hwang B, Park C, Kim H, Yoo K, Jeon D, Jeong M, Seung K, Ahn Y, Chang K

February 19, 2021 | 10.4244/EIJ-D-20-00187

Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Chieffo A, Tarantini G, Naber C, Barbato E, Roffi M, Stefanini G, Buchanan G, Buszman P, Moreno R, Zawiślak B, Cayla G, Danenberg H, Da Silveira J, Nef H, James S, Mauri Ferre J, Voskuil M, Witt N, Windecker S, Baumbach A, Dudek D

February 19, 2021 | 10.4244/EIJ-D-20-01291

Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study

Milewski K, Takahashi K, Asano T, Katagiri Y, Hochul M, Buszman P, Tomaniak M, Gorycki B, Zurakowski A, Janas A, Mlodziankowski A, Kachel M, Wykrzykowska J, Wijns W, de Winter R, Buszman P, Onuma Y, Serruys P

February 19, 2021 | 10.4244/EIJ-D-18-01201

Prognostic significance of thermodilution-derived coronary flow capacity in patients with deferred revascularisation

Hoshino M, Kanaji Y, Hamaya R, Kanno Y, Hada M, Yamaguchi M, Sumino Y, Usui E, Murai T, Lee T, Yonetsu T, Kakuta T

February 19, 2021 | 10.4244/EIJ-D-19-00029

Impact of chronic total coronary occlusion revascularisation on infarct-related myocardial scars responsible for recurrent ventricular tachycardia

Myat A, Patel M, Silberbauer J, Hildick-Smith D

February 19, 2021 | 10.4244/EIJ-D-18-01117

Interventions for valvular disease

Outcomes of Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation by Severity of Left Ventricular Dysfunction

Lerakis S, Kini A, Asch F, Kar S, Lim DS, Mishell JM, Whisenant BK, Grayburn P, Weissman N, Rinaldi M, Sharma S, Kapadia S, Rajagopal V, Sarembock I, Brieke A, Tang G, Li D, Crowley A, Lindenfeld J, Abraham WT, Mack M, Stone G

February 16, 2021 | 10.4244/EIJ-D-20-01265

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

News

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

March 4, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

March 2, 2021

Guidance Papers

Guidelines, consensus & position papers